Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology.

Nature Protocols
P P JacobsN Callewaert

Abstract

Here we provide a protocol for engineering the N-glycosylation pathway of the yeast Pichia pastoris. The general strategy consists of the disruption of an endogenous glycosyltransferase gene (OCH1) and the stepwise introduction of heterologous glycosylation enzymes. Each engineering step results in the introduction of one glycosidase or glycosyltransferase activity into the Pichia endoplasmic reticulum or Golgi complex and consists of a number of stages: transformation with the appropriate GlycoSwitch vector, small-scale cultivation of a number of transformants, sugar analysis and heterologous protein expression analysis. If desired, the resulting clone can be further engineered by repeating the procedure with the next GlycoSwitch vector. Each engineering step takes approximately 3 weeks. The conversion of any wild-type Pichia strain into a strain that modifies its glycoproteins with Gal(2)GlcNAc(2)Man(3)GlcNAc(2)N-glycans requires the introduction of five GlycoSwitch vectors. Three examples of the full engineering procedure are provided to illustrate the results that can be expected.

References

Jan 1, 1985·Annual Review of Biochemistry·R Kornfeld, S Kornfeld
Jul 1, 1994·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·P H Weigel
Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·C L YipV L MacKay
Jul 29, 1998·Methods in Molecular Biology·J M Cregg, K A Russell
Jan 8, 1999·Biochimica Et Biophysica Acta·N Dean
Jan 21, 2000·FEMS Microbiology Reviews·J L Cereghino, J M Cregg
Mar 9, 2002·Science·Sena J LeeMichel C Nussenzweig
Sep 27, 2002·Current Opinion in Biotechnology·Geoff P Lin CereghinoJames M Cregg
Aug 30, 2003·Science·Stephen R HamiltonTillman U Gerngross
May 7, 2004·Applied and Environmental Microbiology·Wouter VerveckenRoland Contreras
Oct 11, 2005·Protein Expression and Purification·Satheesh K SainathanBrian K Dieckgraefe
Jan 24, 2006·Nature Biotechnology·Huijuan LiTillman U Gerngross
Sep 9, 2006·Science·Stephen R HamiltonTillman U Gerngross
Apr 5, 2007·Nature Protocols·Wouter LaroyNico Callewaert
Nov 28, 2007·Applied and Environmental Microbiology·Kousuke KurodaYoshifumi Jigami

❮ Previous
Next ❯

Citations

Feb 14, 2009·Biotechnology Letters·Anjali Apte-DeshpnadeSriram Padmanabhan
Apr 30, 2013·The Journal of Microbiology·Edwin David Morales-ÁlvarezOlga Y Echeverri-Peña
Dec 7, 2011·ACS Chemical Biology·Lai-Xi Wang, Joseph V Lomino
Apr 12, 2012·Journal of the American Chemical Society·Thomas J StyslingerPeng G Wang
Sep 6, 2012·The Journal of Biological Chemistry·Alexandra CastilhoRichard Strasser
Jan 7, 2011·FEMS Yeast Research·Rongqing PanXin Yan
Dec 4, 2012·Applied and Environmental Microbiology·Farnoush Parsaie NasabAlexander Daniel Frey
Oct 20, 2009·Microbial Cell Factories·Diethard MattanovichKristof De Schutter
Apr 23, 2014·Nature Biotechnology·Leander MeurisNico Callewaert
Apr 20, 2014·Applied Microbiology and Biotechnology·Mudassar AhmadHelmut Schwab
Sep 26, 2015·International Journal of Molecular Sciences·Simona CaponeOliver Spadiut
Jul 16, 2015·Expert Opinion on Biological Therapy·Martina Dicker, Richard Strasser
Jan 1, 2010·Expert Opinion on Drug Discovery·Alain BeckThierry Wurch
Jul 16, 2015·Biotechnology and Bioengineering·Alexander KinnaKerry Chester
Jul 23, 2011·Journal of Biotechnology·Jozef AnnéKristel Bernaerts
Jan 20, 2015·Future Microbiology·Bram LaukensNico Callewaert
Apr 24, 2016·Biochimica Et Biophysica Acta·Ngoc Phuong Lan LeMax Crispin
Jun 2, 2015·Biotechnology Advances·V LooserK Kovar
Dec 3, 2016·Human Vaccines & Immunotherapeutics·Isabelle LegasteloisBettina Werle
Oct 15, 2014·Biotechnology Progress·Hagen MüllerPeter Czermak
Jul 12, 2014·Current Opinion in Biotechnology·Michael A Meehl, Terrance A Stadheim
Mar 6, 2017·Microbial Cell Factories·Laia GifreElena Garcia-Fruitós
Feb 9, 2017·Acta Crystallographica. Section F, Structural Biology Communications·William B O'DellFlora Meilleur
Dec 22, 2017·Critical Reviews in Biotechnology·Justin Bryan Goh, Say Kong Ng
Jun 9, 2018·Bioscience, Biotechnology, and Biochemistry·Diane MutumwinkaMorihisa Fujita
Jan 2, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·John J LewinGeoffrey Ling
Feb 12, 2010·Biotechnology and Bioengineering·Kerry Routenberg LoveJ Christopher Love
Mar 18, 2010·Plant Biotechnology Journal·Véronique GomordLoïc Faye
Jun 30, 2010·Applied Microbiology and Biotechnology·Karen De PourcqNico Callewaert
Apr 6, 2019·Applied Microbiology and Biotechnology·Lisa Van RenterghemWim Soetaert
Apr 17, 2019·Preparative Biochemistry & Biotechnology·Brian EfferGisele Monteiro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.